ZIVO BIOSCIENCE, INC. Research and Development in Process
ZIVO BIOSCIENCE, INC. (ZIVO) reported Research and Development in Process of $1.50 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2023-03-14
- ZIVO BIOSCIENCE, INC. research and development in process for the quarter ending 2022-12-31 was $200.48K, a 100.00% decline year-over-year.
- ZIVO BIOSCIENCE, INC. research and development in process for the quarter ending 2022-09-30 was $418.52K, a 69.57% increase year-over-year.
- ZIVO BIOSCIENCE, INC. research and development in process for the quarter ending 2022-06-30 was $327.00K, a 74.87% increase year-over-year.
- ZIVO BIOSCIENCE, INC. research and development in process for the quarter ending 2022-03-31 was $554.00K.
- ZIVO BIOSCIENCE, INC. research and development in process for fiscal 2022 was $1.50M, a 100.00% decline from fiscal 2021.
- ZIVO BIOSCIENCE, INC. research and development in process for fiscal 2021 was $800.00B.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|
| 2022-12-31 | $200.48K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $619.00K derived: sum of 2 quarters · filed 2023-03-14 | $946.00K derived: sum of 3 quarters · filed 2023-03-14 | $1.50M 10-K · filed 2023-03-14 |
| 2022-09-30 | $418.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $745.52K derived: sum of 2 quarters · filed 2022-11-14 | $1.30M 10-Q · filed 2022-11-14 | $800.00B derived: sum of 4 quarters · filed 2023-03-14 |
| 2022-06-30 | $327.00K 10-Q · filed 2022-08-04 | $881.00K 10-Q · filed 2022-08-04 | $800.00B derived: sum of 3 quarters · filed 2023-03-14 | $800.00B derived: sum of 4 quarters · filed 2023-03-14 |
| 2022-03-31 | $554.00K derived: 10-K 12 month − 3 quarters · filed 2023-03-14 | $800.00B derived: sum of 2 quarters · filed 2023-03-14 | $800.00B derived: sum of 3 quarters · filed 2023-03-14 | $800.00B derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-12-31 | $800.00B derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $800.00B derived: sum of 2 quarters · filed 2023-03-14 | $800.00B derived: sum of 3 quarters · filed 2023-03-14 | $800.00B 10-K · filed 2023-03-14 |
| 2021-09-30 | $246.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $433.82K derived: sum of 2 quarters · filed 2022-11-14 | $841.82K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $187.00K 10-Q · filed 2022-08-04 | $595.00K 10-Q · filed 2022-08-04 |